Lead articlePatterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas
Introduction
Renal cell carcinomas (RCCs) represent 85–90% of all kidney tumors; the incidence is currently on a rising trend, especially in Europe and North America as compared to Asia and Africa. Frequently, the patients have metastases at the time of diagnosis or develop distant metastases following removal of the primary tumor 1, 2, 3. Histopathological classification separates the different types of RCCs into several categories of neoplasms, but classification can sometimes be difficult, partly due to the fact that histologic features may become highly anaplastic during tumor progression, and partly because differences between the histologic categories are sometimes ambiguous [4]. According to the Heidelberg classification [5] based on genomic alterations, two major groups were defined among the malignant neoplasms: (1) the conventional clear cell carcinomas characterized by the loss of the short arm of chromosome 3, the duplication of the 5q22 region and the deletion of chromosome arms 6q, 8p, 9p, and 14q (about 85% of cases); and (2) the papillary carcinomas characterized by trisomy of chromosomes 3q, 7, 8, 12, 16, 17, and 20 and loss of the Y chromosome (10–15% of cases). The identification of stable, characteristic genomic alterations, which occur during establishment and/or progression of the disease, is now considered as a useful approach to pinpoint new predisposing genes and candidate genes involved in tumor progression for both hereditary and sporadic forms of RCCs 2, 3, 6, 7. Thus, the new pathological classification can now take into account the results of such genomic analyses to complement the histopathological data in order to improve diagnosis and predict prognosis 8, 9.
We have previously shown that the tumorigenicity of a series of metastatic RCCs xenografted into immunodeficient (SCID) mice correlated with a poor clinical prognosis [10] and, in the xenografts established from papillary tumors, the main genomic alterations were maintained [11]. In a primary papillary RCC, a minor clone displayed minichromosomes carrying the minimal duplicated region overlapping the 7q31 band and containing the MET proto-oncogene. The MET gene was found to be present in the minimal overrepresented region from chromosome 7 common to three different papillary tumors 11, 12. We report here data showing a recurrence of associated chromosomal alterations specific to conventional or papillary RCC subtypes in xenografts obtained after a few passages into SCID mice. The results also disclose a relationship between some of these characteristic chromosomal alterations, the tumor growth rate of the xenografts in mice and a poor prognosis. The possible significance at the molecular level of some specific genomic duplications in the progression of RCCs is taken into consideration.
Section snippets
Histological features of tumors
Twenty RCCs were established as xenografts in SCID mice [10] and 13 were chosen for cytogenetic analysis. Six xenografts were derived from metastatic lesions (RCC-1, -3, -10, -43, -44, and -49) and seven from primary tumors (RCC-7, -16, -17, -28, -41, -45, and -47) with a Furhman nuclear grade from 1 to 3 [13].
Histological analysis was performed on acetic acid-formaline-ethanol fixed tissue specimens embedded in paraffin. In order to verify the relationship with the original tissue, the
Frequency of associated genomic alterations disclosed by xenografting
As shown in Table 1, 7 xenografted tumors displayed the genetic trait of the conventional subtype (loss of 3p), and 5 showed the genetic features of the papillary subtype (integrity of 3p and duplication of 7q). In all cases where a comparison between initial and xenografted tumor was possible (3 out of 7 conventional tumors and 4 out of 5 papillary tumors), the chromosomal abnormalities of each individual tumor were found to be maintained in the xenografts.
The main chromosomal abnormalities of
Discussion
In this report, we determine patterns of specific genomic anomalies found in xenografted conventional and papillary RCCs. Our results suggest that the identification of genetic alterations specifically associated with more aggressive tumor phenotypes could be useful for the diagnosis and predicting the prognosis of RCCs.
The minimal region deleted in the short arm of chromosome 3, in our conventional RCCs, was the 3p14∼pter region. This region includes the 3p25 region where the von Hippel-Lindau
Acknowledgements
This work was supported by the Association pour la Recherche sur le Cancer (grant no. 9105 to A. Bernheim and grant no. 9849 to B. Perbal), the Institut Gustave Roussy, the Ligue Nationale Contre le Cancer and the CNRS. L. Glukhova held a fellowship from the Fondation pour la Recherche Médicale and the Association pour le Recherche sur le Cancer.
References (31)
- et al.
Clinical significance of cytogenetic findings in solid tumors
Cancer Genet Cytogenet
(1997) - et al.
Histopathology and molecular genetics of renal tumorsToward unification of a classification system
J Urol
(1999) - et al.
Involvement of chromosome 7 in Wilms' tumor
Cancer Genet Cytogenet
(1995) - et al.
The CCN family of angiogenic regulatorsthe integrin connection
Exp Cell Res
(1999) The modular architecture of a new family of growth regulators related to connective tissue growth factor
FEBS Lett
(1993)- et al.
Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation
Gene
(1999) - et al.
Renal cell carcinomarecent progress and future directions
Cancer Res
(1997) - et al.
Renal cancergenetic and cytogenetic aspects
Molecular genetics of renal carcinogenesis
Toxicol Pathol
(1998)- et al.
Classification of renal cell carcinomaWorkgroup No1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
Cancer
(1997)
The Heidelberg classification of renal cell tumors
J Pathol
Inherited carcinomas of the kidney
Adv Cancer Res
Molecular genetics and diagnosis of renal cell tumors
Urologe
Human renal cell carcinoma xenografts in SCID micetumorigenicity correlates with a poor clinical prognosis
Lab Invest
Overrepresentation of 7q31 and 17q in renal cell carcinomas
Genes Chromosom Cancer
Cited by (46)
Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence
2016, BreastCitation Excerpt :This complexity is reflected in conflicting reports of its significance in cancer biology. While CCN3 has been reported to exert growth-suppressive effects in several cancer types, paradoxically, it has also been shown to have a pro-migration and pro-metastatic role in melanoma [92] and Ewing's sarcoma [93] and high levels predict poor prognosis in prostate cancer [94], osteosarcoma [95] and renal cell cancer [96]. In breast cancer, reports have also been contradictory, with some reporting an association with good prognosis [97] and others reporting association with resistance to endocrine therapy [98].
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone
2011, American Journal of PathologyCCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease
2009, American Journal of PathologyCitation Excerpt :We have previously shown that during normal nephrogenesis, CCN3 protein is tightly associated with normal differentiation of glomerular podocytes and is expressed in Wilms' tumors.16 A number of reports demonstrate a link between cancer cell growth and CCN3 expression, most showing an inverse relationship.12,29,30 Additionally, a recent report has shown a role for CCN3 as a regulator of human hematopoietic stem or progenitor cell growth.31
Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms
2009, Human PathologyCitation Excerpt :In familial cases, trisomy of chromosome 7 is characterized by a nonrandom duplication of a mutant c-MET allele. Duplication of this mutant gene via trisomy of chromosome 7q31 appears to be involved in the development of papillary renal cell carcinomas in this subset of patients [69,70]. Duplications of mutated c-MET are associated with a greater growth stimulatory effect [71].
Differential expression of chicken hepatic genes responsive to PFOA and PFOS
2007, ToxicologyCitation Excerpt :NOV protein with the N-terminal truncated form could cause transformation of chicken embryo fibroblasts by its oncogenic activity. The development of several tumors of different origins, including Wilm's tumor, renal cell carcinoma, neuroblastoma, glioblastoma, adrenocortical carcinoma, and musculoskeletal tumors, was associated with the up-regulation of NOV (Glukhova et al., 2001; Gupta et al., 2001; Manara et al., 2002; Thomopoulos et al., 2001). In this study, NOV was induced by some doses of PFOS and PFOA (Table 7).
Structural and Functional Properties of CCN Proteins
2005, Vitamins and HormonesCitation Excerpt :Although expression of full-length CCN3 has a growth inhibitory effect in chicken embryo fibroblasts, expression of an N-terminally truncated form of CCN3 can transform these same cells (Joliot et al., 1992). The expression of CCN3 was correlated to increased proliferative index in the case of prostate and renal cell carcinoma (Glukhova et al., 2001; Maillard et al., 2001) and higher metastatic potential of Ewing's carcinoma cells (Manara et al., 2002). In contrast, some tumors (neuroblastomas, chondrosarcomas, rhabdomyosarcomas, and Wilms' tumor) showed high expression of CCN3 that was associated with tumor differentiation and cell growth arrest (Chevalier et al., 1998; Maillard et al., 2001; Perbal, 2001).